CLINICAL_TRIALS
trial_result
· 2024-12-05
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 3]
Summary
Phase 3 study of Reldesemtiv in amyotrophic lateral sclerosis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cytokinetics | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2024-12-05